Information Provided By: 
Fly News Breaks for October 23, 2015
ENTA
Oct 23, 2015 | 06:58 EDT
JMP Securities upgraded Enanta to Outperform and established a $32 price target on shares. Analyst Liisa A. Bayko believes shares have overreacted to the FDA warning on Viekira Pak and the impact to sales will be modest. Bayko said a majority of Enanta's valuation is related to the next-gen combo expected in 2018, which does not include any Viekira Pak components, with peak sales potential of $3B.
News For ENTA From the Last 2 Days
There are no results for your query ENTA
